![Shlomit Valenstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shlomit Valenstein
Chief Operating Officer at HMT Medical Technologies Ltd.
Network origin in Shlomit Valenstein first degree
Entity | Entity type | Industry | |
---|---|---|---|
HMT Medical Technologies Ltd.
![]() HMT Medical Technologies Ltd. Medical SpecialtiesHealth Technology HMT Medical Technologies Ltd. has developed a novel device called "The Splitter" to enable safer and more effective aortic valve replacement procedures. The need for The Splitter arises from the fact that 1.5 million people suffer from aortic stenosis, a complex disease caused by a narrowing or hardening of the aortic valve due to calcium buildup on the heart valve flaps. The Israeli company was founded in 2021 and operates with a highly skilled team in interventional cardiology, medical device development, and commercialization. The CEO is Shlomo Lewkowicz.
1
| Holding Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Shlomit Valenstein via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Endobetix Ltd.
![]() Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | Medical Specialties | Founder |
Statistics
International
Israel | 2 |
Sectoral
Health Technology | 2 |
Operational
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Most connected contacts
Insiders | |
---|---|
Shlomo Lewkowicz | 2 |
- Stock Market
- Insiders
- Shlomit Valenstein
- Company connections